Download Download
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
New Patient Paperwork: Women
The Texas Center for Reproductive Acupuncture ______________________________________________________________ Patient Intake Form: Women __________________________________________________________________________________________________________________________________________________________________________________________________________________ Important: The information on this form will help your acupuncturist to give you the best and most comprehensive care possible. It is important for you to complete this document as thoroughly as possible. Even though some of the questions may seem completely unrelated to your condition, they may play a contributing, or underlying role in diagnosis and treatment of your problem. __________________________________________________________________________________________________________________________________________________________________________________________________________________ General Patient Information (All of the information provided is strictly confidential – see permission to share medical information section) Last Name: _____________________________ First Name: _______________________________ Middle Initial: _______ Age: ______ Primary Telephone Number: ____________________________________ Alternative Phone # ______________________________________ E-Mail: ____________________________________ Date of Birth ____ / _____ / _____ Today’s Date ___/___/_____ Number of Name of your Menstrual Cycle Pregnancies Age menstruation began: _______ Cesarean Births Ob/Gyn: __________________________________________ -
Estimation of a Lower Bound for the Cumulative Incidence of Failure Of
CHAPTER 1 Introduction 11 1.1 Background The incidence of failure of a method for contraception is generally a matter of great interest to any person who uses, or whose sexual partner uses, that method. Not surprisingly, there is a large volume of research into the failure rates of all of the temporary methods for human contraception. However, there is a much more modest literature on the cumulative incidence of failure and annual failure rates of permanent sterilisation, particularly failures of female tubal sterilisation - often called “tubal ligation”, but including any means for occluding or interrupting the Fallopian tubes by surgical means. This is somewhat surprising given that female tubal sterilisation remains one of the most popular and widely used means of contraception. The Australian Study of Health and Relationships, which was conducted between May 2001 and June 2002 using a representative sample of 9,134 women aged 16 to 59 years, found that of the two-thirds of respondents who reported using some form of contraception, 22.5 per cent relied on tubal ligation or hysterectomy (these were not further distinguished), which was second in popularity only to oral contraceptives.1 The proportion of women in the 40-49 year age group who relied on tubal ligation or hysterectomy was 33 per cent, which was second in popularity only to vasectomy in the partner (34.6 per cent). In the 1995 United States Survey of Family Growth, conducted by the US National Center for Health Statistics, surgical sterilisation was the method of choice in -
Co-Registered Multimodal Endoscope for Early Ovarian Cancer by David
Co-registered Multimodal Endoscope for Early Ovarian Cancer by David Vega __________________________ Copyright © David Vega 2021 A Dissertation Submitted to the Faculty of the WYANT COLLEGE OF OPTICAL SCIENCES In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF PHILOSOPHY In the Graduate College THE UNIVERSITY OF ARIZONA 2021 *$$)*&+!"**)++"&%&$$"++.)+"/+!+.!-)+!"**)++"&% ')')/ +"+# %)&$$%+!+"+'+*,#"##"% +!"**)++"&%)(,")$%+&)+! )&&+&)&!"#&*&'!/ +05/14/2021 + 05/14/2021 + "%#'')&-#%'+%&+!"*"**)++"&%"*&%+"% %+,'&%+!%"+0**,$"**"&% &+!"%#&'"*&+!"**)++"&%+&+! ),+&## !)/)+"/+!+ !-)+!"*"**)++"&%')'),%)$/")+"&%%)&$$% +!+"+'+*,#"##"% +!"**)++"&%)(,")$%+ +05/14/2021 "**)++"&%&$$"++!") 3 STATEMENT BY AUTHOR This dissertation has been submitted in partial fulfillment of the requirements for an advanced degree at the University of Arizona and is deposited in the University Library to be made available to borrowers under rules of the Library. Brief quotations from this dissertation are allowable without special permission, provided that an accurate acknowledgement of the source is made. Requests for permission for extended quotation from or reproduction of this manuscript in whole or in part may be granted by the head of the major department or the Dean of the Graduate College when in his or her judgment the proposed use of the material is in the interests of scholarship. In all other instances, however, permission must be obtained from the author. SIGNED: David Vega 4 DEDICATION A mi familia. -
Obstetrics and Gynecology Clinical Privilege List
Obstetrics and Gynecology Clinical Privilege List Description of Service Alberta Health Services (AHS) Medical Staff who are specialists in Obstetrics and Gynecology (or its associated subspecialties) and have privileges in the Department of Obstetrics and Gynecology provide safe, high quality care for obstetrical and gynecologic patients in AHS facilities across the province. The specialty encompasses medical, surgical, obstetrical and gynecologic knowledge and skills for the prevention, diagnosis and management of a broad range of conditions affecting women's gynecological and reproductive health. Working to provide a patient-focused, quality health system that is accessible and sustainable for all Albertans, the department also offers subspecialty care including gynecological oncology, reproductive endocrinology, maternal fetal medicine, urogynecology, and minimally invasive surgery.1 Obstetrics and Gynecology privileges may include admitting, evaluating, diagnosing, treating (medical and/or surgical management), to female patients of all ages presenting in any condition or stage of pregnancy or female patients presenting with illnesses, injuries, and disorders of the gynecological or genitourinary system including the ability to assess, stabilize, and determine the disposition of patients with emergent conditions consistent with medical staff policy regarding emergency and consultative call services. Providing consultation based on the designated position profile (clinical; education; research; service), and/or limited Medical Staff -
Final Program
SCIENTIFIC PROGRAM CHAIR Arnold P. Advincula, M.D. 43rd AAGL PRESIDENT Ceana H. Nezhat, M.D. GLOBAL CONGRESS HONORARY CHAIR ON MINIMALLY INVASIVE GYNECOLOGY Farr R. Nezhat, M.D. NOV. 17-21, 2014 | Vancouver, British Columbia HONORARY MEMBER Victor Gomel, M.D. FINAL PROGRAM Experience Excellence in Education The AAGL Global Congress is the pre-eminent meeting for physicians interested in providing optimal patient care through minimally invasive gynecology. Designed to meet the needs of practicing surgeons, residents and fellows, operating room personnel and other allied healthcare professionals, the Congress covers traditional topics as well as presentations of “cutting edge” material. With opportunities to discuss and share discoveries, you will experience excellence in formal, informal and collegial education. Take control of port site closure with the Weck EFx® Closure System SUPPORT WOMEN’S HEALTH AT AAGL 2014 Visit Teleflex booth 431 and support women’s health with the Weck EFx Quick Closure Challenge. Teleflex will donate $10,000 to help support the advancement of gynecological laparoscopy to the organization with the highest number of votes submitted by successful Challenge participants.* Confidence. Clarity. Control. Universal design accommodates Consistent and uniform 1 cm A TRUE unassisted approach both standard and bariatric fascial purchase 180 degrees to port site closure. anatomy for 10–15 mm defects. across the defect. *For complete rules and eligibility, visit us at www.weckefx.com/QuickClosureChallenge Teleflex, Weck EFx -
Association Between History of Abdominopelvic Surgery and Tubal Pathology
Association between history of abdominopelvic surgery and tubal pathology *Famurewa O1, Adeyemi A2, Ibitoye O1, Ogunsemoyin O3 1. Department of Radiology, Obafemi Awolowo University and Obafemi Awolowo University Teaching Hospital, Nigeria 2. Department of Obstetrics & Gynaecology, Obafemi Awolowo University, Nigeria 3. Department of Radiology, Obafemi Awolowo University Teaching Hospital, Nigeria Abstract Background: Pelvic infection, unsafe abortion and previous laparatomy are risk factors for tubal infertility among Nigerian women. Reports on the relationship between these factors and tubal pathology seen on hysterosalpingography (HSG) from our environment have been few. Objective: To assess the prevalence of tubal occlusions among patients referred for HSG and examine the association between previous history of abdominopelvic surgery (including dilatation and curettage for abortion) and tubal occlusion. Methods: We studied one hundred and thirty women referred to the Radiology department for HSG because of infertility. HSG was performed during the early proliferative phase of the menstrual cycle. Information about type and duration of infertility, history of abdomino -pelvic surgery and history suggestive of previous pelvic infection, were obtained from the patients. The data obtained were analyzed using SPSS version 11.Test of association using the chi-square test was done where appropriate and differences were considered at p= 0.05. Results: Sixty one women had bilaterally patent tubes; tubal pathology was seen in sixty nine women. Significant association exits between tubal pathology and history of pelvic surgery p=0.01, pelvic infection p=0.02 and duration of infertility p=0.04. Conclusion: Previous surgery especially dilation and curettage, PID duration and type of infertility are associated with tubal pathology among Nigerian women. -
Advances in Training for Laparoscopic and Robotic Surgery
Advances in Training for Laparoscopic and Robotic Surgery Henk Schreuder Advances in Training for Laparoscopic and Robotic Surgery Vooruitgang in training van laparoscopische en robot geassisteerde chirurgie (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit van Utrecht op gezag van de rector magnificus, prof. dr. G.J. van der Zwaan ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op woensdag 2 november 2011 des middags om 12.45 uur Advances in Training for Laparoscopic and Robotic Surgery Author: Henk W.R. Schreuder Cover design: Gordon Nealy, Mimic Technologies, Seattle and Gerrit Cats Lay-out: Barbara Hagoort, Multimedia, UMC Utrecht, Netherlands Printed by: Ipskamp Drukkers, Enschede, The Netherlands ISBN/EAN: 978-94-6191-010-3 © Copyright 2011 H.W.R.Schreuder No part of this thesis may be reproduced, stored in a retrieval system of any nature, or transmitted in any form or by any means, without written permission of the author door Publication of this thesis was supported by 3-Dmed®, Bayer Schering Nederland, BMA BV (Mosos), Covidien Nederland BV, Division of Woman & Baby (UMC Utrecht), Dutch Society for Simulation in Healthcare (DSSH), Ferring B.V., Hendrik Willem Rudolf Schreuder GlaxoSmithKline, Ipsen Farmaceutica B.V., Johnson & Johnson Medical BV, Krijnen Medical geboren 19 oktober 1966 te Haarlem Innovations B.V., Medical Dynamics, Memidis Pharma b.v., Merck Sharp & Dohme BV, Mimic Technologies Inc., Nederlandse Vereniging voor Endoscopische Chirurgie (NVEC), Nycomed bv, Olympus Nederland B.V., Raadgevers Kuijkhoven, Sigma Medical, Simendo BV, Skills Meducation, Stöpler Instrumenten en Apparaten, Surgical Science Sweden AB, Toshiba Medical Systems Nederland, Van Beek Medical bv., Welmed B.V., ZekVinos Promotor: Prof. -
Fertiloscopy – an Overview W Law, a Watrelot
The Internet Journal of Gynecology and Obstetrics ISPUB.COM Volume 12 Number 2 Fertiloscopy – An Overview W Law, A Watrelot Citation W Law, A Watrelot. Fertiloscopy – An Overview. The Internet Journal of Gynecology and Obstetrics. 2009 Volume 12 Number 2. Abstract BackgroundThe introduction of fertiloscopy has revolutionized the investigation and treatment of patients with unexplained infertility. Hitherto, this group of patients have been either been subjected to ineffective treatment, or been ‘over treated’. TechniqueAs fertiloscopy is a relatively new technique, it is essential for practitioners to be educated regarding the proper techniques in order to carry out the procedure successfully with minimal complications. The five important steps in fertiloscopy are described in detail. Evidence Acquisition/ JustificationA multicentre prospective randomized study (FLY) was conducted to compare both fertiloscopy and laparoscopy as first line investigations for infertile patients. The conclusion of FLY study was that: “Fertiloscopy should replace laparoscopy in infertile women with no obvious pathology”. ConclusionFertiloscopy is at least as accurate as laparoscopy and dye test, with less risk and morbidity. In addition, fertiloscopy allows the evaluation of tubal mucosa. Hence, fertiloscopy should be seriously considered as the first line investigation for infertile patients. BACKGROUND A third alternative is by offering an abdominal laparoscopy. The management of unexplained infertility has always been This is the currently the accepted “gold standard” for challenging. This is because if the cause of infertility is not establishing causes of infertility due to pathologies in the established, treatment decision is basically based on fallopian tubes or the pelvis structures surrounding the therapeutic trial. This is far from ideal and will subsequently uterus.(2,3) However, laparoscopy is a non-trivial surgical result in emotional, physical and financial strains. -
TABLE of SURGICAL PROCEDURES (Updated As of 2 Jan 2019)
Ministry of Health TABLE OF SURGICAL PROCEDURES (Updated as of 2 Jan 2019) 1 TABLE OF CONTENTS SA - Integumentary ........................................................................... 3 SB - Musculoskeletal ....................................................................... 10 SC - Respiratory .............................................................................. 27 SD - Cardiovascular ........................................................................ 30 SE - Hemic & Lymphatic ................................................................. 37 SF - Digestive .................................................................................. 39 SG - Urinary .................................................................................... 51 SH - Male Genital ............................................................................ 55 SI - Female Genital ......................................................................... 57 SJ - Endocrine ................................................................................. 64 SK - Nervous ................................................................................... 65 SL - Eye ........................................................................................... 72 SM - ENT ......................................................................................... 78 The Table of Surgical Procedures (TOSP) is an exhaustive list of procedures with table ranking 1A to 7C, for which MediSave / MediShield Life can be claimed. Any procedures not listed -
CHAPTER Gynaecological Procedures 13
Propunere noua clasificare proceduri folosind codificarea ICD-10-AM versiunea 3, 30 martie 2004 Institutul National de Cercetare-Dezvoltare in Sanatate / Centrul de Calcul, Statistica Sanitara si Documentare Medicala CHAPTER 13 Gynaecological Procedures BLOCK 1240 Application, insertion or removal procedures on ovary 35518-00 Aspiration of ovarian cyst BLOCK 1241 Incision procedures on ovary 35637-08 Laparoscopic ovarian drilling 35713-03 Ovarian drilling 35637-07 Laparoscopic rupture of ovarian cyst or abscess 35713-02 Rupture of ovarian cyst or abscess BLOCK 1242 Biopsy of ovary 35637-06 Biopsy of ovary BLOCK 1243 Oophorectomy 35638-03 Laparoscopic oophorectomy, bilateral 35638-02 Laparoscopic oophorectomy, unilateral 35638-01 Laparoscopic partial oophorectomy 35638-00 Laparoscopic wedge resection of ovary 35713-07 Oophorectomy, unilateral 35717-01 Oophorectomy, bilateral 35713-05 Wedge resection of ovary 35713-06 Partial oophorectomy BLOCK 1244 Other excision procedures on ovary 35638-05 Laparoscopic ovarian cystectomy, bilateral 35638-04 Laparoscopic ovarian cystectomy, unilateral 35713-04 Ovarian cystectomy, unilateral 35717-00 Ovarian cystectomy, bilateral BLOCK 1245 Transposition of ovary 35729-01 Transposition of ovary 35729-00 Laparoscopic transposition of ovary BLOCK 1246 Other repair procedures on ovary 90430-01 Other repair of ovary 90430-00 Other laparoscopic repair of ovary BLOCK 1247 Other procedures on ovary 90431-00 Other procedures on ovary BLOCK 1248 Application, insertion or removal procedures on fallopian tube 35710-00 -
Tubal Infertility Related Chlamydia
Tubal disease and Infertility Tim Chang April 2009 The fallopian tube is 7-14cm in length connecting the ovary/peritoneal cavity to the uterus. Functions: • Mechanical conduit for sperm and egg and zygote transport • Functional secretion of nutrients, “fertility” factors for egg, sperm interaction, fertiltization and early embryo support Tubal factor infertility accounts for 30% female factor infertiltiy Aetiology: • Infection - ascending (Chlamydia/GC anerobes) . PID 1-2% females 15-39 . Incidence chlamydia infection increasing since 1984 . 2/3 tubal infertility related chlamydia . <50% tubal infertility patients have history PID . each episode PID increases risk infertility from 10%-20%-40% after 1-2 -3 attacks PID. - appendix • endometriosis • inflammatory lesions e.g. SIN . endometriosis . polyps . mucous plugs (proximal tubes) • fibroids especially uterotubal junction Tim Chang Page 1 of 17 Tubal Infertility 2009 Prognosis depends on: • location damage o proximal 20% o distal 80% • extent of damage • nature damage eg inflammatory vs iatrogenic • treatment techniques: microsurgery vs IVF Classification of tubal disease severity Variety classifications of tubal disease, but there is no simple system which can give accurate prognosis Most classifications combine HSG with laparoscopy to give score Internal architecture of tubes and physiology of the tube is not widely available Most classifications look at: • size tube / hydrosalpinx (normal < 15mm) • rugal pattern on HSG • adhesions • state of fimbria • muscular thickness of tube PR EP mild 70% vs 10-20% with no treatment 10% moderate 30-50% 25% severe 0-15% >50% Natural fertility without treatment overall 2-10% after 12 months. NB: • large thick walled hydrosalpinx <15% pregnancy rate after tubal surgery therefore IVF better. -
SHA –KASP-PMJAY Scheme – Inclusion of Standard Treatment Guidelines 11(Stgs) – Mandatory Documents Reg
File No.SHA/675/2020-MGR(HNQA) To All Superintendents of AB PM-JAY-KASP Empanelled Private Hospitals And Government Hospitals Sub: SHA –KASP-PMJAY Scheme – Inclusion of Standard Treatment Guidelines 11(STGs) – Mandatory Documents reg. Ref: 1.DO No.S-12015/08/2019-NHA (HNW &QA) (Pt.1) (Vol.2) Dated 27/07/2020 Kind attention to the references cited. The National Health Authority (NHA) has developed and integrated the Standard Treatment Guidelines (STGs) / Guidance documents for health benefit packages under AB PM-JAY KASP in TMS.NHA has decided to launch the 11th set of 20 STGs and make live in the PM- JAY KASP IT system by 02.12.2020. The mandatory documents for claim adjudication are as attached for reference. STG Procedures – Mandatory Documents 1. Acromioclavicular (AC) Joint reconstruction / Stabilization AC Joint reconstruction / Stabilization - Rockwood Type – I - SB032A AC Joint reconstruction / Stabilization – Rockwood Type – II - SB032B AC Joint reconstruction / Stabilization – Rockwood Type – III - SB032C AC Joint reconstruction / Stabilization – Rockwood Type – IV - SB032D AC Joint reconstruction / Stabilization – Rockwood Type – V - SB032E AC Joint reconstruction / Stabilization – Rockwood Type – VI - SB032F Mandatory document Rockwoo d type I-VI i. At the time of Pre-authorization a. Clinical notes confirming the diagnosis Yes b. X-ray/ MRI labelled with patient ID, date and side (Left/ Right) of Yes affected limb ii. At the time of claim submission a. Detailed Indoor case papers (ICPs) Yes b. Post-op X-ray labelled with patient ID, date and side (Left/ Right) of Yes operated limb c. Post Procedure clinical photograph (Optional) Yes d.